Tixagevimab Antibody
Tixagevimab is a humanized monoclonal antibody that neutralizes SARS-CoV-2 by binding to the spike protein's receptor-binding domain, preventing viral entry. It is utilized in research applications for both in vitro neutralization assays and in vivo preclinical studies of COVID-19 therapeutics and prophylaxis.
Product Specifications
Product Name Alternative
AZD8895, AZD 8895
Target
SARS-CoV
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Concentration
10.61 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
146.48 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV773404 1.0 µg DNA
PSME2P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details 
E44H11722 100 µL
PCNA Monoclonal Antibody (12D10), AbFluor™ 488 Conjugated
Sign In for Pricing
View Details MBS1288857 Inquire
Recombinant Human B-cell CLL/lymphoma 9-like protein (BCL9L) , partial
Sign In for Pricing
View Details